Gladius Capital Management LP Selecta Biosciences Inc Transaction History

Gladius Capital Management LP

  • $166 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 18, 2023
BUY
$1.04 - $1.4 $17,828 - $24,000
17,143 New
17,143 $19,000
Q2 2023

Aug 08, 2023
BUY
$1.04 - $1.4 $17,828 - $24,000
17,143 New
17,143 $20,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email